SNDX - Syndax Pharmaceuticals Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call Transcript
Syndax Pharmaceuticals, Inc. (SNDX) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Melissa Forst - Argot Partners, Investor Relations Briggs Morrison - Chief Executive Officer Michael Metzger - President, Chief Operating Officer and Director Anjali Ganguli - Chief Business Officer Conference Call Participants Phil Nadeau - Cowen Justin Walsh - B. Riley Securities Joel Beatty - Baird Peter Lawson - Barclays Presentation Operator Good day and thank you for standing by. Welcome to the Syndax Third Quarter 2021 Conference Call. [Operator instructions] I would now like to hand the conference over to your first speaker today, Melissa Forst with Argot Partners. Thank you. And please go ahead now. Melissa Forst Thank you, operator. Welcome and thank you to those of you joining us on the line and the webcast this afternoon for a review of Syndax's third quarter 2021 financial and operating results. With me
For further details see:
Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call Transcript